Director sold
~$923KReported value · 6,000 sh @ $153.91
Stock since the trade +7.8% · S&P 500 +13.3% · to Oct 5
A board member of Balchem sold $923K of Balchem shares. Nobody planned it ahead of time.
Loading…
BCPC · NASDAQ · Specialty Chemicals
Specialty Chemicals company based in Montvale, New Jersey.
In the last 90 days, no insider of Balchem Corporation reported an open-market purchase and 0 open-market sales. Every figure links to its official SEC, House, Senate or USAspending record.
Last closeLast close, Oct 5, 2026
$166.04
Last 12 months
Not enough history
Market value
$5.29B
Revenue
$284M
+11.2% vs the same quarter a year earlier
Free cash flow, last 12 months
—
Cash from operations minus capital spending
Net debt
—
Debt —, cash $63.2M, at Jun 30, 2026
Net income, last 12 months
$164M
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Jul 31, 2026.
Insiders buying, last 90 days
None
No open-market purchases reported
Insiders selling, last 90 days
None
No open-market sales reported
New federal contracts, 12 months
None
Nothing found for this company
Revenue, fiscal 2025
$1.04B
+8.8% vs the year before
Net income, fiscal 2025
$155M
As reported in the annual filing
Shares outstanding
31.9M
As of Jul 23, 2026
In fiscal 2025 the company spent $108M buying back its own shares and $28.3M on dividends. Cash actually paid, from its cash-flow statement.
Stock since the trade +7.8% · S&P 500 +13.3% · to Oct 5
A board member of Balchem sold $923K of Balchem shares. Nobody planned it ahead of time.
Stock since the trade +8.3% · S&P 500 +13.2% · to Oct 5
Balchem's SVP and GM, Specialty Products sold $648K of Balchem shares. Nobody planned it ahead of time.
Stock since the trade +7.8% · S&P 500 +13.3% · to Oct 5
A board member of Balchem sold $308K of Balchem shares. Nobody planned it ahead of time.
Stock since the trade +8.3% · S&P 500 +13.2% · to Oct 5
Balchem's SVP and GM, Specialty Products sold $271K of Balchem shares. Nobody planned it ahead of time.
Stock since the trade +6.4% · S&P 500 +13.4% · to Oct 5
Balchem's SVP Chief Supply Chain Officer sold $185K of Balchem shares. Nobody planned it ahead of time.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Last 12 months, adjusted daily closes
Adjusted close went from $143.16 on Oct 6, 2025 to $166.04 on Oct 5, 2026 (+16.0%). Disclosed activity in the last 12 months: 0 insider purchases, 5 insider sales, 0 Congress purchases, 0 Congress sales.